characteristics.text: SAMN14601766
characteristics.characteristic: External Id
characteristics.text: respiratory medicine, Tsukuba university
characteristics.characteristic: INSDC center name
characteristics.text: 2023-04-15T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-04-15T01:22:30.190Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS6483852
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS6483852
characteristics.characteristic: SRA accession
characteristics.text: no
characteristics.characteristic: act-responder
characteristics.text: no
characteristics.characteristic: ae-responder
characteristics.text: severe eosinophilic asthma
characteristics.characteristic: disease state
characteristics.text: no
characteristics.characteristic: fev1-responder
characteristics.text: no
characteristics.characteristic: gete-responder
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Whole blood cells
characteristics.characteristic: source_name
characteristics.text: 4 months after starting of benralizumab treatment
characteristics.characteristic: time point
characteristics.text: Whole blood cells
characteristics.characteristic: tissue
characteristics.text: 24_4M
characteristics.characteristic: title